ESC & iPSC News Volume 16.43 | Nov 3 2021

    0
    127







    2021-11-03 | ESC 16.43


    ESC & iPSC News by STEMCELL Technologies
    Vol. 16.43 – 3 November, 2021
    TOP STORY

    Ribonuclease Recruitment Using a Small Molecule Reduced c9ALS/FTD r(G4C2) Repeat Expansion In Vitro and In Vivo ALS Models

    Scientists demonstrated that targeted small-molecule degradation of an expanded G4C2 RNA repeat was a strategy for mitigating amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD)-associated pathologies and studying disease-associated pathways in preclinical models.
    [Science Translational Medicine]

    Full Article

    Return to your lab safely and efficiently with these guides and resources so that you can focus more on moving your research goals forward.
    PUBLICATIONSRanked by the impact factor of the journal

    ATP-Binding Cassette Protein ABCF1 Couples Transcription and Genome Surveillance in Embryonic Stem Cells through Low-Complexity Domain

    The authors reported the ATP-binding cassette subfamily F member 1 (ABCF1) as a coactivator for OCT4/SOX2 critical for stem cell self-renewal.
    [Science Advances]

    Full Article

    Inner Nuclear Protein Matrin-3 Coordinates Cell Differentiation by Stabilizing Chromatin Architecture

    Destabilization of CCCTC-binding factor and cohesin binding correlated with altered transcription and accelerated differentiation. This association was conserved in ESCs.
    [Nature Communications]

    Full Article

    Gain-of-Function Cardiomyopathic Mutations in RBM20 Rewire Splicing Regulation and Re-Distribute Ribonucleoprotein Granules within Processing Bodies

    To understand the mechanism of RBM20-associated dilated cardiomyopathy (DCM), researchers engineered isogenic iPSCs with DCM-associated missense mutations in RBM20 as well as RBM20 knockout iPSCs.
    [Nature Communications]

    Full Article

    Integrated Loss- and Gain-of-Function Screens Define a Core Network Governing Human Embryonic Stem Cell Behavior

    Investigators described an integrated genome-scale loss- and gain-of-function screening approach to identify genetic networks governing ESC proliferation and differentiation into the three germ layers.
    [Genes & Development]

    Abstract

    Inherent Genomic Properties Underlie the Epigenomic Heterogeneity of Human Induced Pluripotent Stem Cells

    Scientists showed that seven human iPSC lines with variable germline potential exhibited substantial epigenomic heterogeneity, despite their uniform transcriptomes.
    [Cell Reports]

    Full ArticleGraphical Abstract

    MK2 Promotes Tfcp2l1 Degradation via β-TrCP Ubiquitin Ligase to Regulate Mouse Embryonic Stem Cell Self-Renewal

    The authors demonstrated that β-transducin repeat-containing protein (β-TrCP) targeted Tfcp2l1 for ubiquitination and degradation in a mitogen-activated protein kinase-activated protein kinase 2 (MK2)-dependent manner.
    [Cell Reports]

    Full ArticleGraphical Abstract

    CALR Frameshift Mutations in MPN Patient-Derived iPSCs Accelerate Maturation of Megakaryocytes

    Scientists generated patient-derived CALRins5- or CALRdel52-positive iPSCs to establish a myeloproliferative neoplasms disease model for molecular and mechanistic studies.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Cell Division- and DNA Replication-Free Reprogramming of Somatic Nuclei for Embryonic Transcription

    Researchers showed that somatic nuclei transferred into mouse four-cell embryos arrested at the G2/M phase underwent reprogramming toward the embryonic state.
    [iScience]

    Full ArticleGraphical Abstract

    The Specialized Mitotic Behavior of Human Embryonic Stem Cells

    Investigators established a cell line of human ESCs stably expressing GFP-α-tubulin and mCherry-H2B by lentiviral infection to analyze and visualize mitosis in detail.
    [Cell and Tissue Research]

    Abstract

    Human iPS Cell Derived RPE Strips for Secure Delivery of Graft Cells at a Target Place with Minimal Surgical Invasion

    The authors produced a quickly formed human iPSC-retinal pigment epithelium (RPE) strip in as short as 2 days, which showed a potency to partly expand with the correct apical/basal polarity in vivo, although limited in expansion area in the presence of healthy host RPE.
    [Scientific Reports]

    Full Article

    Watch this innovation showcase from ISSCR 2021 on applications of hPSC-derived lung models.
    REVIEWS

    Induced Pluripotency in the Context of Stem Cell Expansion Bioprocess Development, Optimization, and Manufacturing: A Roadmap to the Clinic

    The complexity and volatility of human iPSCs present several bioprocessing challenges, where the goal is to generate a sufficiently large, high-quality, homogeneous population for downstream differentiation — the derivatives of which must retain functional efficacy and meet regulatory safety criteria in application.
    [NPJ Regenerative Medicine]

    Full Article

    Fumarylacetoacetate Hydrolase Gene as a Knockout Target for Hepatic Chimerism and Donor Liver Production

    Investigators review proposed mutations in the recipient embryo to disable hepatogenesis and discuss the advantages of using fumarylacetoacetate hydrolase knockouts and other genetic modifications to disable hepatogenesis.
    [Stem Cell Reports]

    Full Article

    INDUSTRY AND POLICY NEWS

    Exacis Biotherapeutics Announces Strategic Partnership with CCRM for Specialty Manufacturing of Services and Investment for Development of iPSC-Derived mRNA-Engineered NK Cells

    Exacis Biotherapeutics, Inc. announced initiation of a strategic partnership with Toronto-based Centre for Commercialization of Regenerative Medicine (CCRM) for specialty manufacturing services related to the development of Exacis’ innovative, iPSC-derived mRNA-engineered natural killer cell products to treat cancer.
    [Exacis Biotherapeutics, Inc. (PR Newswire, Inc.)]

    Press Release

    FEATURED EVENT

    Cell Bio Virtual 2021

    December 1 – 10, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Organoid Development

    Roche – Basel, Switzerland

    Scientist – iPSC Derived Cardiac Tissues

    Columbia University – New York, New York, United States

    Production Manager – Stem Cell and Organoid

    Herophilus – San Francisco, California, United States

    Postdoctoral Research Fellow – iPSC Reprogramming

    Northwestern University – Chicago, Illinois, United States

    Postdoctoral Researcher – Neurodegenerative Disease Modeling

    Buck Institute for Research on Aging – Novato, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter